Ticker Details
Amylyx Pharmaceuticals, Inc.
IPO Date:	January 7, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.91B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.49 | 3.39%
Avg Daily Range (30 D):	$0.47 | 3.21%
Avg Daily Range (90 D):	$0.44 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	1.18M
Avg Daily Volume (30 D):	.88M
Avg Daily Volume (90 D):	1.04M

Trade Size
Avg Trade Size (Sh.):	93
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	1,694
Avg Institutional Trade:	$1.85M
Avg Institutional Trade (30 D):	$2M
Avg Institutional Trade (90 D):	$2.03M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.34M
Avg Closing Trade (30 D):	$2.34M
Avg Closing Trade (90 D):	$2.53M
Avg Closing Volume:	159.25K

News

Feb 19, 2026 @ 8:30 AM Global Amyotrophic Lateral Sclerosis Therapeutics ... Source: Custom Market Insights

Aug 28, 2025 @ 5:00 PM Antisense Oligonucleotide Therapeutics Clinical Tr... Source: Delveinsight

Jul 14, 2025 @ 10:26 PM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C.

Jul 8, 2025 @ 1:00 AM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C.

Oct 18, 2024 @ 11:26 AM Why Amylyx Pharmaceuticals Stock Was So Healthy Th... Source: Eric Volkman

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.53	$-.28	$-1.53
Diluted EPS	$-1.53	$-.28	$-1.53
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-144.74M	$-33M	$-144.74M
Operating Income / Loss	$-153.29M	$-36.61M	$-153.29M
Cost of Revenue	$M	$M	$M
Net Cash Flow	$148.8M	$1.48M	$148.8M
PE Ratio